FDA Bans Unapproved Prescription Cough, Cold and Allergy Meds (HealthDay)

HealthDay - WEDNESDAY, March 2 (HealthDay News) -- The U.S. Food and Drug Administration said Wednesday that it plans to remove about 500 unapproved prescription cough, cold, and allergy medicines from pharmacy shelves.

FDA cracks down on untested cold medicines (AP)

AP - The Food and Drug Administration said Wednesday that it will remove roughly 500 unapproved cold and allergy medications from the market as part of an ongoing crackdown on ineffective prescription drugs.

US pulls 500 unauthorized prescription drugs (AFP)

AFP - The US Food and Drug Administration on Wednesday said it wants 500 unauthorized prescription drugs for cough, cold and allergy symptoms pulled from the market because of risks to the public.

Designer drug abuse out of control: UN drugs board (Reuters)

Reuters - The problem of so-called "designer drugs" is running out of control in many regions of the world, the U.N. global drugs watchdog said on Wednesday.

Designer drug abuse out of control: U.N. drugs board (Reuters)

Reuters - The problem of so-called "designer drugs" is running out of control in many regions of the world, the U.N. global drugs watchdog said Wednesday.

Merck says US rejects its MS drug (AFP)

AFP - German pharmaceutical group Merck KgaA said Wednesday that the US Food and Drug Administration (FDA) has refused to approve use of its multiple sclerosis treatment Cladribine.

FDA approves roflumilast for severe COPD

FDA approved the first-and-only selective phosphodiesterase type 4 inhibitor roflumilast (Daliresp, Forest Pharmaceuticals), once-daily oral tablet to decrease the frequency of exacerbations or worsening of symptoms from severe chronic obstructive pulmonary disease.

FDA approves guanfacine ER tablets to treat ADHD in children, teens

FDA approved the use of once-daily guanfacine (Intuniv, Shire) extended-release tablets as adjunctive therapy to stimulants for the treatment of attention deficit hyperactivity disorder in children and adolescents aged 6 to 17 years as part of a total treatment program.

Clinical Trials Update: March 1, 2011 (HealthDay)

HealthDay - (HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:

Blood Pressure Drugs May Help Heart Patients Without Hypertension (HealthDay)

HealthDay - TUESDAY, March 1 (HealthDay News) -- In people with heart disease, the use of blood pressure-lowering medications can be beneficial, even in those who don't have high blood pressure, new research suggests.

« Previous Page — Next Page »